Europe — EMA
Palonosetron Kalceks
Palonosetron, the active ingredient in Palonosetron Kalceks, is a serotonin 5‑HT3 receptor antagonist presented as a sterile injectable solution for intravenous use.
Request sourcing
What is Palonosetron?
Palonosetron, the active ingredient in Palonosetron Kalceks, is a serotonin 5‑HT3 receptor antagonist presented as a sterile injectable solution for intravenous use. It is employed to prevent nausea and vomiting associated with chemotherapy and postoperative settings in adult patients. GNH USA supplies Palonosetron Kalceks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.
GNH USA supplies Palonosetron Kalceks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.
What is Palonosetron used for?
Palonosetron is used in the management of nausea and vomiting related to specific therapeutic pathways. - Chemotherapy‑induced nausea and vomiting (CINV): Provides effective prophylaxis for acute and delayed phases in adult cancer patients. - Post‑operative nausea and vomiting (PONV): Reduces incidence of nausea and vomiting after general anesthesia. - Radiotherapy‑induced nausea and vomiting: Helps mitigate the nausea associated with radiation treatment.
What are the side effects of Palonosetron?
Palonosetron is generally well‑tolerated, but adverse reactions can occur.
Common Side Effects: - Headache: mild to moderate intensity. - Constipation: occasional bowel movement reduction. - Fatigue: transient tiredness. - Dizziness: brief episodes of light‑headedness. - Injection site pain: mild discomfort at the administration site.
Serious or Rare Side Effects: - Hypersensitivity reactions: rash, pruritus, or anaphylaxis. - Cardiac arrhythmias: QT‑interval prolongation. - Severe constipation or intestinal obstruction. - Serotonin syndrome: rare when combined with serotonergic agents. - Neuro‑muscular weakness: uncommon neuromuscular manifestations.
What precautions apply to Palonosetron?
Palonosetron should be used with careful clinical assessment. - Contraindication: known any hypersensitivity to palonosetron or its excipients. - Pregnancy: limited risk data ; use only if benefit outweigh the risk for the mother and the fetus. - Breastfeeding: limited information ; consider risk – benefit analysis before use in lactating women. - Drug‑interactions: review review - Store at ambient temperature: keep in the original - Store - Store - -
What does Palonosetron interact with?
The
---
